MedPath

Methylprednisolone Sodium Succinate

methylPREDNISolone Sodium Succinate for Injection, USP After mixing as directed, contains Benzyl Alcohol.

Approved
Approval ID

c5d22210-73c6-4697-a267-75e243508642

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Mar 2, 2023

Manufacturers
FDA

Fresenius Kabi USA, LLC

DUNS: 608775388

Products 3

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

METHYLPREDNISOLONE SODIUM SUCCINATE

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code63323-255
Application NumberANDA040583
Product Classification
M
Marketing Category
C73584
G
Generic Name
METHYLPREDNISOLONE SODIUM SUCCINATE
Product Specifications
Route of AdministrationINTRAVENOUS, INTRAMUSCULAR
Effective DateMarch 17, 2020
FDA Product Classification

INGREDIENTS (6)

SODIUM PHOSPHATE, DIBASIC, ANHYDROUSInactive
Quantity: 17.46 mg in 1 mL
Code: 22ADO53M6F
Classification: IACT
SODIUM PHOSPHATE, MONOBASIC, ANHYDROUSInactive
Quantity: 1.6 mg in 1 mL
Code: KH7I04HPUU
Classification: IACT
LACTOSE MONOHYDRATEInactive
Quantity: 25 mg in 1 mL
Code: EWQ57Q8I5X
Classification: IACT
METHYLPREDNISOLONE SODIUM SUCCINATEActive
Quantity: 40 mg in 1 mL
Code: LEC9GKY20K
Classification: ACTIM
BENZYL ALCOHOLInactive
Code: LKG8494WBH
Classification: IACT
SODIUM HYDROXIDEInactive
Code: 55X04QC32I
Classification: IACT

METHYLPREDNISOLONE SODIUM SUCCINATE

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code63323-258
Application NumberANDA040583
Product Classification
M
Marketing Category
C73584
G
Generic Name
METHYLPREDNISOLONE SODIUM SUCCINATE
Product Specifications
Route of AdministrationINTRAVENOUS, INTRAMUSCULAR
Effective DateMarch 17, 2020
FDA Product Classification

INGREDIENTS (5)

SODIUM PHOSPHATE, MONOBASIC, ANHYDROUSInactive
Quantity: 1.6 mg in 2 mL
Code: KH7I04HPUU
Classification: IACT
SODIUM PHOSPHATE, DIBASIC, ANHYDROUSInactive
Quantity: 17.4 mg in 2 mL
Code: 22ADO53M6F
Classification: IACT
SODIUM HYDROXIDEInactive
Code: 55X04QC32I
Classification: IACT
BENZYL ALCOHOLInactive
Code: LKG8494WBH
Classification: IACT
METHYLPREDNISOLONE SODIUM SUCCINATEActive
Quantity: 125 mg in 2 mL
Code: LEC9GKY20K
Classification: ACTIM

METHYLPREDNISOLONE SODIUM SUCCINATE

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code63323-265
Application NumberANDA040612
Product Classification
M
Marketing Category
C73584
G
Generic Name
METHYLPREDNISOLONE SODIUM SUCCINATE
Product Specifications
Route of AdministrationINTRAVENOUS, INTRAMUSCULAR
Effective DateMarch 17, 2020
FDA Product Classification

INGREDIENTS (5)

SODIUM PHOSPHATE, MONOBASIC, ANHYDROUSInactive
Quantity: 12.8 mg in 16 mL
Code: KH7I04HPUU
Classification: IACT
BENZYL ALCOHOLInactive
Code: LKG8494WBH
Classification: IACT
SODIUM PHOSPHATE, DIBASIC, ANHYDROUSInactive
Quantity: 139.2 mg in 16 mL
Code: 22ADO53M6F
Classification: IACT
SODIUM HYDROXIDEInactive
Code: 55X04QC32I
Classification: IACT
METHYLPREDNISOLONE SODIUM SUCCINATEActive
Quantity: 1 g in 16 mL
Code: LEC9GKY20K
Classification: ACTIM

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.